VEGFA c.77C>T ;(p.A26V)

Variant ID: 6-43738520-C-T

NM_003376.5(VEGFA):c.77C>T;(p.A26V)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Integrative omics analyses broaden treatment targets in human cancer.

Genome Medicine
Sengupta, Sohini S; Sun, Sam Q SQ; Huang, Kuan-Lin KL; Oh, Clara C; Bailey, Matthew H MH; Varghese, Rajees R; Wyczalkowski, Matthew A MA; Ning, Jie J; Tripathi, Piyush P; McMichael, Joshua F JF; Johnson, Kimberly J KJ; Kandoth, Cyriac C; Welch, John J; Ma, Cynthia C; Wendl, Michael C MC; Payne, Samuel H SH; Fenyö, David D; Townsend, Reid R RR; Dipersio, John F JF; Chen, Feng F; Ding, Li L
Publication Date: 2018-07-27

Variant appearance in text: VEGFA: A26V
PubMed Link: 30053901
Variant Present in the following documents:
  • 13073_2018_564_MOESM2_ESM.xlsx, sheet 10
  • 13073_2018_564_MOESM2_ESM.xlsx, sheet 8
View BVdb publication page



Somatic and germline mutation in GRIM-19, a dual function gene involved in mitochondrial metabolism and cell death, is linked to mitochondrion-rich (Hurthle cell) tumours of the thyroid.

British Journal Of Cancer
Máximo, V V; Botelho, T T; Capela, J J; Soares, P P; Lima, J J; Taveira, A A; Amaro, T T; Barbosa, A P AP; Preto, A A; Harach, H R HR; Williams, D D; Sobrinho-Simões, M M
Publication Date: 2005-05-23

Variant appearance in text: VEGF: A26V
PubMed Link: 15841082
Variant Present in the following documents:
  • Main text
  • 92-6602547a.pdf
View BVdb publication page